Las Vegas, NV -- (SBWIRE) -- 01/09/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Frontline Ltd(NYSE:FRO), Orexigen Therapeutics, Inc.(NASDAQ:OREX), Neurocrine Biosciences, Inc.(NASDAQ:NBIX), NII Holdings Inc(NASDAQ:NIHD)
Frontline Ltd(NYSE:FRO) was a volume gainer of 4.37 million shares and the average volume of the stock remained 1.94 million shares. The stock opened the session at $4.49 and finished at the end of the day at $4.61 and the stock escalated 5.73%.The market capitalization of the stock remained 363.47 million. Frontline Ltd., through its subsidiaries, engages in the ownership and operation of oil tankers. The company provides seaborne transportation of crude oil and oil products, as well as raw materials, such as coal and iron ore.
For How Long FRO will fight for Profitability? Read This Trend Analysis report
In the preceding trading session, Orexigen Therapeutics, Inc.(NASDAQ:OREX) exchanged 4.22 million shares and the average volume remained 3.25 million shares. The stock closed the session at $5.99 with the gain of 2.92%. Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Orexigen Therapeutics, Inc. was founded in 2002 and is headquartered in La Jolla, California.
Will OREX Continue To Move Higher? Find Out Here
Neurocrine Biosciences, Inc.(NASDAQ:NBIX) decreased -2.34% and its closing price was $18.08. The volume of the stock was 4.22 million shares and the average volume remained 1.18 million shares. The market capitalization of the stock remained 1.22 billion. The beta of the stock remained 0.13. Neurocrine Biosciences, Inc. engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. It develops drugs for endometriosis, and other neurological and endocrine-related diseases and disorders.
Will NBIX Get Buyers Even After The Recent Rally? Find Out Here
NII Holdings Inc(NASDAQ:NIHD) exchanged 3.70 million shares in the previous trading session, and its average trading remained 5.96 million shares. NIHD dropped -3.83% and it closed the trading at $2.51. The market capitalization of the stock remained 432.82 million. NII Holdings, Inc., through its subsidiaries, provides wireless communication services under the Nextel brand name to businesses and individuals in Mexico, Brazil, Argentina, Peru, and Chile. The company was formerly known as Nextel International, Inc. and changed its name to NII Holdings, Inc. in December 2001.
Has NIHD Found The Bottom and Ready To Move Up? Find Out Here
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)